This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Ian Windsor - Innovator in HIV Protease Inhibition
Introduction
Ian Windsor is a notable inventor based in Wisconsin Rapids, WI (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target HIV protease. His innovative work has the potential to enhance treatment options for individuals affected by HIV.
Latest Patents
Windsor holds a patent for "Boronic acid inhibitors of HIV protease." This invention focuses on protease inhibitors, specifically aspartyl protease inhibitors, which are boronated to improve their activity and facilitate entry into cells. The compounds, prodrugs, and salts associated with this invention contain phenylboronate groups, such as p-B(OH)-phenyl groups, benzoxaborole groups, or borono-pyridyl groups. These compounds are designed to provide methods for treating AIDS and AIDS-related complex (ARC), as well as preventing HIV infection.
Career Highlights
Ian Windsor is affiliated with the Wisconsin Alumni Research Foundation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on public health and the treatment of viral infections.
Collaborations
Windsor has collaborated with esteemed colleagues, including Ronald Thaddeus Raines and Michael Palte. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Ian Windsor's innovative contributions to the field of HIV protease inhibition exemplify the importance of research in combating viral infections. His work not only enhances our understanding of medicinal chemistry but also offers hope for improved treatment options for those affected by HIV.